ReferenceRRK5387

JUNIPER

AN OPEN-LABEL EXTENSION AND SAFETY MONITORING STUDY OF PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE PREVIOUSLY ENROLLED IN THE ETROLIZUMAB PHASE III PROTOCOL GA29144

Research Summary

Research Overview
PI Name Iqbal - T
Speciality
Sponsor F. Hoffman-La Roche
Project Status Open
Proposed End Date 14/07/2022
Study Run through CRF? Yes
Recruitment so far 1